Marjo Nylund
MSc
Turku PET Centre marjo.k.nylund@utu.fi +358 29 450 4743 +358 50 472 8266 Itäinen Pitkäkatu 4 Turku ORCID identifier: https://orcid.org/0000-0001-6695-5684 |
Publications 
1 of 2
- Integrating TSPO-PET imaging with metabolomics for enhanced prognostic accuracy in multiple sclerosis (2025)
- BMJ neurology open
(A1 Refereed original research article in a scientific journal) - A Novel Comprehensive Epigenomic Liquid Biopsy Assay Reveals Disease Biology in Multiple Sclerosis Patients from 1 mL of Plasma (2024)
- Multiple Sclerosis
(Abstract) - P2X 7-receptor binding in new-onset and secondary progressive MS – a [11C]SMW139 PET study (2024)
- EJNMMI Research
(A1 Refereed original research article in a scientific journal) - Sex-driven variability in TSPO-expressing microglia in MS patients and healthy individuals (2024)
- Frontiers in Neurology
(A1 Refereed original research article in a scientific journal) - Synaptic density in multiple sclerosis: An in vivo study using [11C]UCB-J-PET imaging (2024)
- Multiple Sclerosis
(Abstract) - TSPO-PET-measurable microglial activity remains unaltered in cladribine-treated RRMS patients (2024)
- Multiple Sclerosis
(Poster) - Early prognosticators of later TSPO-PET-measurable microglial activation in multiple sclerosis (2023)
- Multiple Sclerosis and Related Disorders
(A1 Refereed original research article in a scientific journal) - Longitudinal stability of progression-related microglial activity during teriflunomide treatment in patients with multiple sclerosis (2023)
- European Journal of Neurology
(A1 Refereed original research article in a scientific journal) - PET-measurable innate immune cell activation reduction in chronic active lesions in PPMS brain after rituximab treatment: a case report (2023)
- Journal of Neurology
(B1 Non-refereed article in a scientific journal) - TSPO-Detectable Chronic Active Lesions Predict Disease Progression in Multiple Sclerosis (2023)
- Neurology, Neuroimmunology and Neuroinflammation
(A1 Refereed original research article in a scientific journal) - Innate Immune Cell-Related Pathology in the Thalamus Signals a Risk for Disability Progression in Multiple Sclerosis (2022)
- Neurology, Neuroimmunology and Neuroinflammation
(A1 Refereed original research article in a scientific journal) - Phenotyping of multiple sclerosis lesions according to innate immune cell activation using TSPO-PET (2022)
- Brain Communications
(A1 Refereed original research article in a scientific journal) - Brain TSPO-PET predicts later disease progression independent of relapses in multiple sclerosis (2020)
- Brain
(A1 Refereed original research article in a scientific journal) - Drug reaction with eosinophilia and systemic symptoms after ocrelizumab therapy (2020)
- Multiple Sclerosis and Related Disorders
(B1 Non-refereed article in a scientific journal) - Frequency and etiology of acute transverse myelitis in Southern Finland (2020)
- Multiple Sclerosis and Related Disorders
(A1 Refereed original research article in a scientific journal) - Insights into disseminated MS brain pathology with multimodal diffusion tensor and PET imaging (2020)
- Neurology, Neuroimmunology and Neuroinflammation
(A1 Refereed original research article in a scientific journal) - Rituximab in the treatment of multiple sclerosis in the Hospital District of Southwest Finland (2020)
- Multiple Sclerosis and Related Disorders
(A1 Refereed original research article in a scientific journal) - Serum glial fibrillary acidic protein correlates with multiple sclerosis disease severity (2020)
- Multiple Sclerosis
(A1 Refereed original research article in a scientific journal) - Natalizumab treatment reduces microglial activation in the white matter of the MS brain (2019)
- Neurology, Neuroimmunology and Neuroinflammation
(A1 Refereed original research article in a scientific journal) - Rituksimabi MS-taudin hoidossa (2019)
- Duodecim
(A1 Refereed original research article in a scientific journal)
UTU Research Portal